spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online September 20, 2006
doi: 10.1242/10.1242/jcs.03098


Journal of Cell Science 119, 3901-3903 (2006)
Published by The Company of Biologists 2006
This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Humphries, J. D.
Right arrow Articles by Humphries, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Humphries, J. D.
Right arrow Articles by Humphries, M. J.

Cell Science at a Glance

Integrin ligands at a glance

Jonathan D. Humphries*, Adam Byron* and Martin J. Humphries{ddagger}

Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK

{ddagger} Author for correspondence (e-mail: martin.humphries{at}manchester.ac.uk)


    Introduction
 Top
 Introduction
 Aims of this article
 Integrin-ligand partners
 Additional integrin-ligand...
 Lessons from evolution
 References
 
Integrins are one of the major families of cell adhesion receptors (Humphries, 2000Go; Hynes, 2002Go). All integrins are non-covalently linked, heterodimeric molecules containing an {alpha} and a ß subunit. Both subunits are type I transmembrane proteins, containing large extracellular domains and mostly short cytoplasmic domains (Springer and Wang, 2004Go; Arnaout et al., 2005Go). Mammalian genomes contain 18 {alpha} subunit and 8 ß subunit genes, and to date 24 different {alpha}-ß combinations have been identified at the protein level. Although some subunits appear only in a single heterodimer, 12 integrins contain the ß1 subunit, and five contain {alpha}V.

Integrin function has been determined through a combination of cell biological and genetic analyses. On the cytoplasmic face of the plasma membrane, integrin occupancy coordinates the assembly of cytoskeletal polymers and signalling complexes; on the extracellular face, integrins engage either extracellular matrix macromolecules or counter-receptors on adjacent cell surfaces. These bidirectional linkages impose spatial restrictions on signalling and extracellular matrix assembly, and thereby integrate cells with their microenvironment. In turn, membrane-proximal interactions initiate more distal functions such as tissue patterning (extracellularly) and cell fate determination (intracellularly). Genetic analyses of engineered or natural mutations have confirmed key roles for integrins in tissue integrity, cell trafficking, and differentiation (Bouvard et al., 2001Go; Bokel and Brown, 2002Go).


    Aims of this article
 Top
 Introduction
 Aims of this article
 Integrin-ligand partners
 Additional integrin-ligand...
 Lessons from evolution
 References
 
A characteristic feature of most integrin receptors is their ability to bind a wide variety of ligands. Moreover, many extracellular matrix and cell surface adhesion proteins bind to multiple integrin receptors (Humphries, 1990Go; Plow et al., 2000Go; van der Flier and Sonnenberg, 2001Go). In recent years, structure-function analyses of both integrins and their ligands have revealed a similar mode of molecular interaction that explains this promiscuity. Nonetheless, the integrin literature is replete with studies describing different integrin-ligand pairs, and the major aim of this article is to provide a clarification of this picture.


Figure 1
View larger version (74K):
[in this window]
[in a new window]
 
 
The poster shows the major integrin-ligand combinations, using hypothetical cell surfaces. We have not attempted a comprehensive cataloguing, but instead we have consulted with a number of colleagues and reached a consensus view on the best-validated integrin ligands. There are many other ligands for different integrins, the inclusion of which would overly complicate the poster. By citing the best studied receptor-ligand combinations, we are aware that some reports and low-affinity interactions (which are nonetheless functionally relevant) may be discriminated against, and for this we apologise. Some of the interactions that are supported by convincing data are nonetheless included below.


    Integrin-ligand partners
 Top
 Introduction
 Aims of this article
 Integrin-ligand partners
 Additional integrin-ligand...
 Lessons from evolution
 References
 
Historically, most integrin-ligand pairs have been identified either by affinity chromatography or through the ability of subunit-specific monoclonal antibodies to block adhesion of cells to specific ligands. In some cases, direct protein-protein binding assays have been used to support biochemical or cell biological data. Despite their wide variety, it is possible to cluster integrin-ligand combinations into four main classes, reflecting the structural basis of the molecular interaction. These classes do not necessarily reflect evolutionary relationships.

RGD-binding integrins
All five {alpha}V integrins, two ß1 integrins ({alpha}5, {alpha}8) and {alpha}IIbß3 share the ability to recognise ligands containing an RGD tripeptide active site. Crystal structures of {alpha}Vß3 and {alpha}IIbß3 complexed with RGD ligands have revealed an identical atomic basis for this interaction (Xiong et al., 2002Go; Xiao et al., 2004Go). RGD binds at an interface between the {alpha} and ß subunits, the R residue fitting into a cleft in a ß-propeller module in the {alpha} subunit, and the D coordinating a cation bound in a von Willebrand factor A-domain in the ß subunit. The RGD-binding integrins are among the most promiscuous in the family, with ß3 integrins in particular binding to a large number of extracellular matrix and soluble vascular ligands. Although many ligands are shared by this subset of integrins, the rank order of ligand affinity varies, presumably reflecting the preciseness of the fit of the ligand RGD conformation with the specific {alpha} active site pockets.

LDV-binding integrins
{alpha}4ß1, {alpha}4ß7, {alpha}9ß1, the four members of the ß2 subfamily and {alpha}Eß7 recognise related sequences in their ligands. {alpha}4ß1, {alpha}4ß7 and {alpha}9ß1 bind to an acidic motif, termed `LDV', that is functionally related to RGD. Fibronectin contains the prototype LDV ligand in its type III connecting segment region, but other ligands (such as VCAM-1 and MAdCAM-1) employ related sequences. Although definitive structural information is lacking, it is highly likely that LDV peptides bind similarly to RGD at the junction between the {alpha} and ß subunits. Osteopontin also interacts with {alpha}4ß1, {alpha}4ß7 and {alpha}9ß1, but this apparently involves a different peptide motif, SVVYGLR, and the location of the ligand-binding site has not been identified.

The ß2 family employ a different mode of ligand binding, the major interaction taking place through an inserted A-domain in the {alpha} subunit (see Shimaoka et al., 2003Go for the structure of a complex between the {alpha}L A-domain and ICAM-1). However, despite this fundamental mechanistic difference, the characterised sites within ligands that bind ß2 integrins are structurally similar to the LDV motif. The major difference is that ß1/ß7 ligands employ an aspartate residue for cation coordination whereas ß2 integrins use glutamate. Collectively, therefore, the LDV motif can be described by the consensus sequence L/I-D/E-V/S/T-P/S.

A-domain ß1 integrins
Four {alpha} subunits containing an {alpha}A-domain ({alpha}1, {alpha}2, {alpha}10 and {alpha}11) combine with ß1 and form a distinct laminin/collagen-binding subfamily. Few other validated ligands have been identified for these integrins. A crystal structure of a complex between the {alpha}2 A-domain and a triple-helical collagenous peptide has revealed the structural basis of the interaction, a critical glutamate within a collagenous GFOGER motif providing the key cation-coordinating residue (Emsley et al., 2000Go). Currently, the mechanism of laminin binding is unknown.

Non-{alpha}A-domain-containing laminin-binding integrins
Three ß1 integrins ({alpha}3, {alpha}6 and {alpha}7), plus {alpha}6ß4, are highly selective laminin receptors. Analysis of laminin fragments indicates that these receptors and the A-domain-containing ß1 integrins bind to different regions of the ligands. In neither case has the active site been narrowed down to a particular sequence or residue.


    Additional integrin-ligand interactions
 Top
 Introduction
 Aims of this article
 Integrin-ligand partners
 Additional integrin-ligand...
 Lessons from evolution
 References
 
As discussed above, additional integrin ligands exist that, for the sake of clarity, we do not include in the poster, even though credible evidence exists for them. These ligands, along with their respective integrin partners, are therefore listed here: ADAM family members interact with {alpha}4ß1, {alpha}5ß1, {alpha}6ß1, {alpha}9ß1, {alpha}Vß3 and {alpha}Vß6; COMP interacts with {alpha}5ß1 and {alpha}vß3; connective tissue growth factor interacts with {alpha}Vß3 and {alpha}IIbß3; Cyr61 interacts with {alpha}6ß1, {alpha}IIbß3, {alpha}Vß3 and {alpha}Dß2; E-cadherin interacts with {alpha}2ß1; ESM-1 interacts with {alpha}Lß2; fibrillin interacts with {alpha}5ß1; fibrinogen interacts with {alpha}Dß2; fibronectin interacts with {alpha}Dß2; ICAM-4 interacts with {alpha}4ß1, {alpha}Lß2, {alpha}Mß2, {alpha}Xß2, {alpha}Vß3 and {alpha}IIbß3; LAP-TGFß interacts with {alpha}8ß1 and {alpha}Vß5; MMP-2 interacts with {alpha}Vß3; nephronectin interacts with {alpha}8ß1; L1 interacts with {alpha}5ß1, {alpha}Vß1, {alpha}Vß3 and {alpha}IIbß3; plasminogen interacts with {alpha}Dß2; POEM interacts with {alpha}8ß1; tenascin interacts with {alpha}2ß1; thrombospondin interacts with {alpha}5ß1 and {alpha}6ß1; VEGF-C and VEGF-D interact with {alpha}9ß1; and vitronectin interacts with {alpha}Dß2. Note also that both {alpha}Mß2 and {alpha}Xß2 interact with heparin and negative charges in denatured proteins.


    Lessons from evolution
 Top
 Introduction
 Aims of this article
 Integrin-ligand partners
 Additional integrin-ligand...
 Lessons from evolution
 References
 
The model invertebrates Drosophila melanogaster and Caenorhabditis elegans have a much smaller complement of integrins than vertebrates (Hynes and Zhao, 2000Go). Drosophila has two ß subunits (ßPS and ß{nu}) and five {alpha} subunits. ß{nu} has no known {alpha} subunit partner, but ßPS combines with subunits that cluster with the laminin-binding and RGD-binding integrins. The remaining {alpha} chains form a Drosophila-specific clade. A similar complement of integrins is found in Caenorhabditis elegans, which suggests that the earliest metazoans possessed two primordial integrins: one laminin-specific and one RGD-ligand-specific.

The genome of the early chordate Ciona intestinalis encodes eleven {alpha} and five ß chain genes (Ewan et al., 2005Go). Two Ciona {alpha} chains cluster with laminin-binding subunits and a third clusters with RGD-binding subunits. Surprisingly, eight {alpha} chains contain an {alpha}A-domain that is related to but, distinct from, the vertebrate {alpha}A-domains. Since these subunits are expressed predominantly in blood cells, they may play a role in innate immunity. It therefore seems that collagen-binding capabilities appeared in the chordate lineage after the divergence of ascidians. Of the five Ciona ß chains, one clusters with ß1, one clusters with ß4, and three form an ascidian-specific clade.


    Acknowledgments
 
Work performed in the authors' laboratory that is related to the topic of this manuscript was supported by the Wellcome Trust. A.B. is supported by a BBSRC CASE PhD studentship, sponsored by GlaxoSmithKline. We thank Dean Sheppard, Nancy Hogg, Tim Springer, Mark Ginsberg and Steve Ludbrook for their comments on ligand specificities of different integrin subsets.


    Footnotes
 
* These authors contributed equally to this article Back


    References
 Top
 Introduction
 Aims of this article
 Integrin-ligand partners
 Additional integrin-ligand...
 Lessons from evolution
 References
 

Arnaout, M. A., Mahalingam, B. and Xiong, J. P. (2005). Integrin structure, allostery, and bidirectional signaling. Annu. Rev. Cell Dev. Biol. 21, 381-410.[CrossRef][Medline]

Bokel, C. and Brown, N. H. (2002). Integrins in development: moving on, responding to, and sticking to the extracellular matrix. Dev. Cell. 3, 311-321.[CrossRef][Medline]

Bouvard, D., Brakebusch, C., Gustafsson, E., Aszodi, A., Bengtsson, T., Berna, A. and Fassler, R. (2001). Functional consequences of integrin gene mutations in mice. Circ. Res. 89, 211-223.[Abstract/Free Full Text]

Emsley, J., Knight, C. G., Farndale, R. W., Barnes, M. J. and Liddington, R. C. (2000). Structural basis of collagen recognition by integrin alpha2beta1. Cell 101, 47-56.[CrossRef][Medline]

Ewan, R., Huxley-Jones, J., Mould, A. P., Humphries, M. J., Robertson, D. L. and Boot-Handford, R. P. (2005). The integrins of the urochordate Ciona intestinalis provide novel insights into the molecular evolution of the vertebrate integrin family. BMC Evol. Biol. 5, 31.[CrossRef][Medline]

Humphries, M. J. (1990). The molecular basis and specificity of integrin-ligand interactions. J. Cell Sci. 97, 585-592.[Free Full Text]

Humphries, M. J. (2000). Integrin structure. Biochem. Soc. Trans. 28, 311-339.[Medline]

Hynes, R. O. (2002). Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687.[CrossRef][Medline]

Hynes, R. O. and Zhao, Q. (2000). The evolution of cell adhesion. J. Cell Biol. 150, F89-F96.[Abstract/Free Full Text]

Plow, E. F., Haas, T. A., Zhang, L., Loftus, J. and Smith, J. W. (2000). Ligand binding to integrins. J. Biol. Chem. 275, 21785-21788.[Free Full Text]

Shimaoka, M., Xiao, T., Liu, J. H., Yang, Y., Dong, Y., Jun, C. D., McCormack, A., Zhang, R., Joachimiak, A., Takagi, J. et al. (2003). Structures of the alpha L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell 112, 99-111.[CrossRef][Medline]

Springer, T. A. and Wang, J. H. (2004). The three-dimensional structure of integrins and their ligands, and conformational regulation of cell adhesion. Adv Protein Chem. 68, 29-63.[Medline]

van der Flier, A. and Sonnenberg, A. (2001). Function and interactions of integrins. Cell Tissue Res. 305, 285-298.[CrossRef][Medline]

Xiao, T., Takagi, J., Coller, B. S., Wang, J. H. and Springer, T. A. (2004). Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 432, 59-67.[CrossRef][Medline]

Xiong, J. P., Stehle, T., Zhang, R., Joachimiak, A., Frech, M., Goodman, S. L. and Arnaout, M. A. (2002). Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science 296, 151-155.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. W. Johansson, E. A. B. Kelly, W. W. Busse, N. N. Jarjour, and D. F. Mosher
Up-Regulation and Activation of Eosinophil Integrins in Blood and Airway after Segmental Lung Antigen Challenge
J. Immunol., June 1, 2008; 180(11): 7622 - 7635.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. B. Meads, L. A. Hazlehurst, and W. S. Dalton
The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
Clin. Cancer Res., May 1, 2008; 14(9): 2519 - 2526.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Vallacchi, M. Daniotti, F. Ratti, D. Di Stasi, P. Deho, A. De Filippo, G. Tragni, A. Balsari, A. Carbone, L. Rivoltini, et al.
CCN3/Nephroblastoma Overexpressed Matricellular Protein Regulates Integrin Expression, Adhesion, and Dissemination in Melanoma
Cancer Res., February 1, 2008; 68(3): 715 - 723.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. G. Bharadwaj, K. Rector, and M. A. Simpson
Inducible Hyaluronan Production Reveals Differential Effects on Prostate Tumor Cell Growth and Tumor Angiogenesis
J. Biol. Chem., July 13, 2007; 282(28): 20561 - 20572.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Humphries, J. D.
Right arrow Articles by Humphries, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Humphries, J. D.
Right arrow Articles by Humphries, M. J.